Also categorized in Pre-Clinical:
Abstract | Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA
x hide permanently

Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma.

ncbi.nlm.nih.gov

Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma.

J Pediatr Hematol Oncol. 2017 Apr 03;:

Authors: Coulter DW, Boettner AD, Kortylewicz ZP, Enke SP, Luther JA, Verma V, Baranowska-Kortylewicz J

Abstract Blood-based biomarkers are important in the detection of the disease and in the assessment of responses to therapy.

Mentions: MYCN Biomarkers